Department of Psychiatry, Suzuki Clinic [H.S.], Tokyo 168-0065, Japan.
Department of Psychiatry, Fukui Kinen Hospital [H.H.], [A.T], Kanagawa 238-0115, Japan.
Asian J Psychiatr. 2018 Oct;37:64-66. doi: 10.1016/j.ajp.2018.08.009. Epub 2018 Aug 11.
There have been no naturalistic reports in Japan clarifying the difference of second-generation antipsychotics (SGA) long-acting injections (LAIs) on treatment retention according to severity of patient condition.
This study aimed to investigate the difference in treatment retention between SGA LAIs according to severity of patient condition.
This study demonstrated that, although AOM patients had better rates of treatment retention compared to PP and RLAI for mild cases, the reverse was true for moderate to severe cases.
Because treatment retention rates can differ for each SGA LAI based on the severity of the patient's condition.
在日本，尚无自然主义报告阐明第二代抗精神病药（SGA）长效注射剂（LAI）根据患者病情严重程度对治疗保留的差异。
本研究旨在根据患者病情严重程度，调查 SGA LAI 之间治疗保留的差异。
本研究表明，虽然 AOM 患者在轻度病例中与 PP 和 RLAI 相比，治疗保留率更好，但在中重度病例中则相反。
由于治疗保留率可能因患者病情严重程度的不同而有所不同，因此，每个 SGA LAI 的治疗保留率可能有所不同。
